Co-expression of vascular endothelial growth factor and neuropilin-1 in ovine feto-placental artery endothelial cells

Molecular and Cellular Endocrinology

Volumn 196, Issue 1-2, 2002, Pages 95-106

  Tsoi, Stephen C M ^a   Wen, YunXia ^a   Chung, Jin Young ^a   Chen, DongBao ^a   Magness, Ronald R ^a,b   Zheng, Jing ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Endothelium; Ewe; Neuropilin 1; Placenta; VEGF

Indexed keywords

COMPLEMENTARY DNA; ISOPROTEIN; NEUROPILIN 1; NEUROPILIN 2; RNA BINDING PROTEIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; SIGNAL PEPTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN; VASCULOTROPIN A;

3' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ARTERY ENDOTHELIUM; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA LIBRARY; DNA SEQUENCE; ENDOTHELIUM CELL; FETOPLACENTAL UNIT; GENE CONSTRUCT; GENE INSERTION; GENETIC CODE; HUMAN; MOLECULAR CLONING; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; REGULATORY MECHANISM; RNA BINDING; SEQUENCE HOMOLOGY; SHEEP; WESTERN BLOTTING; ANIMAL; ARTERY; AUTOCRINE EFFECT; CYTOLOGY; EXON; FEMALE; GENETICS; METABOLISM; MOLECULAR GENETICS; PLACENTA; PLACENTA CIRCULATION; PREGNANCY; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; UNTRANSLATED REGION; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; ARTERIES; AUTOCRINE COMMUNICATION; BASE SEQUENCE; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; EXONS; FEMALE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MOLECULAR SEQUENCE DATA; NEUROPILIN-1; PLACENTA; PLACENTAL CIRCULATION; PREGNANCY; PROTEIN ISOFORMS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SHEEP; UNTRANSLATED REGIONS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037206424     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00190-9     Document Type: Article

References (44)

1. Alon T., Hemo I., Itin A., Pe'er J., Stone J., Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1:1995;1024-1028.
2. Barnhart B., Kosinski P.A., Wang Z., Ford G.S., Kiledjian M., Covey L.R. Identification of a complex that binds to the CD154 3′ untranslated region: implications for a role in message stability during T cell activation. J. Immunol. 165:2000;4478-4486.
3. Benjamin L.E., Keshet E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl. Acad. Sci. USA. 94:1997;8761-8766.
4. Berisha B., Schams D., Kosmann M., Amselgruber W., Einspanier R. Expression and localisation of vascular endothelial growth factor and basic fibroblast growth factor during the final growth of bovine ovarian follicles. J. Endocrinol. 167:2000;371-382.
5. Berisha B., Schams D., Kosmann M., Amselgruber W., Einspanier R. Expression and tissue concentration of vascular endothelial growth factor, its receptors, and localization in the bovine corpus luteum during estrous cycle and pregnancy. Biol. Reprod. 63:2000;1106-1114.
6. Cai H., Reed R.R. Cloning and characterization of neuropilin-1-interacting protein: a PSD-95/Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1. J. Neurosci. 19:1999;6519-6527.
7. Caput D., Beutler B., Hartog K., Thayer R., Brown-Shimer S., Cerami A. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA. 83:1986;1670-1674.
8. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:1996;435-439.
9. Carmeliet P., Ng Y.S., Nuyens D., Theilmeier G., Brusselmans K., Cornelissen I., Ehler E., Kakkar V.V., Stalmans I., Mattot V., Perriard J.C., Dewerchin M., Flameng W., Nagy A., Lupu F., Moons L., Collen D., D'Amore P.A., Shima D.T. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5:1999;495-502.
10. Cheung C.Y., Brace R.A. Ovine vascular endothelial growth factor: nucleotide sequence and expression in fetal tissues. Growth Factors. 16:1998;11-22.
11. Claffey K.P., Shih S.C., Mullen A., Dziennis S., Cusick J.L., Abrams K.R., Lee S.W., Detmar M. Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability. Mol. Biol. Cell. 9:1998;469-481.
12. Cooper J.C., Sharkey A.M., McLaren J., Charnock-Jones D.S., Smith S.K. Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunohistochemistry. J. Reprod. Fertil. 105:1995;205-213.
13. Dibbens J.A., Polyak S.W., Damert A., Risau W., Vadas M.A., Goodall G.J. Nucleotide sequence of the mouse VEGF 3′UTR and quantitative analysis of sites of polyadenylation. Biochim. Biophys. Acta. 1518:2001;57-62.
14. Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog. Horm. Res. 55:2000;15-35.
15. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:1996;439-442.
16. Fong G.H., Zhang L., Bryce D.M., Peng J. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development. 126:1999;3015-3025.
17. Gagnon M.L., Bielenberg D.R., Gechtman Z., Miao H.Q., Takashima S., Soker S., Klagsbrun M. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: in vivo expression and antitumor activity. Proc. Natl. Acad. Sci. USA. 97:2000;2573-2578.
18. Gluzman-Poltorak Z., Cohen T., Herzog Y., Neufeld G. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165. J. Biol. Chem. 275:2000;18 040-18 045.
19. Gluzman-Poltorak Z., Cohen T., Shibuya M., Neufeld G. Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes. J. Biol. Chem. 276:2001;18 688-18 694.
20. Halder J.B., Zhao X., Soker S., Paria B.C., Klagsbrun M., Das S.K., Dey S.K. Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation. Genesis. 26:2000;213-224.
21. Houck K.A., Ferrara N., Winer J., Cachianes G., Li B., Leung D.W. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5:1991;1806-1814.
22. Irwin N., Baekelandt V., Goritchenko L., Benowitz L.I. Identification of two proteins that bind to a pyrimidine-rich sequence in the 3′-untranslated region of GAP-43 mRNA. Nucl. Acids Res. 25:1997;1281-1288.
23. Kawakami A., Kitsukawa T., Takagi S., Fujisawa H. Developmentally regulated expression of a cell surface protein, neuropilin, in the mouse nervous system. J. Neurobiol. 29:1996;1-17.
24. Kitsukawa T., Shimizu M., Sanbo M., Hirata T., Taniguchi M., Bekku Y., Yagi T., Fujisawa H. Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron. 19:1997;995-1005.
25. Kitsukawa T., Shimono A., Kawakami A., Kondoh H., Fujisawa H. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development. 121:1995;4309-4318.
26. Klagsbrun M., D'Amore P.A. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor. Rev. 7:1996;259-270.
27. Levy N.S., Chung S., Furneaux H., Levy A.P. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 273:1998;6417-6423.
28. Levy N.S., Goldberg M.A., Levy A.P. Sequencing of the human vascular endothelial growth factor (VEGF) 3′ untranslated region (UTR): conservation of five hypoxia-inducible RNA-protein binding sites. Biochim. Biophys. Acta. 1352:1997;167-173.
29. Liu Y., Cox S.R., Morita T., Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ. Res. 77:(3):1995;638-643.
30. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13:1999;9-22.
31. Ng Y.S., Rohan R., Sunday M.E., Demello D.E., D'Amore P.A. Differential expression of VEGF isoforms in mouse during development and in the adult. Dev. Dyn. 220:2001;112-121.
32. Redmer D.A., Dai Y., Li J., Charnock-Jones D.S., Smith S.K., Reynolds L.P., Moor R.M. Characterization and expression of vascular endothelial growth factor (VEGF) in the ovine corpus luteum. J. Reprod. Fertil. 108:1996;157-165.
33. Reynolds L.P., Redmer D.A. Angiogenesis in the placenta. Biol. Reprod. 64:2001;1033-1040.
34. Rossignol M., Gagnon M.L., Klagsbrun M. Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms. Genomics. 70:2000;211-222.
35. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., Schuh A.C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 376:1995;62-66.
36. Sharkey A.M., Charnock-Jones D.S., Boocock C.A., Brown K.D., Smith S.K. Expression of mRNA for vascular endothelial growth factor in human placenta. J. Reprod. Fertil. 99:1993;609-615.
37. Shaw G., Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 46:1986;659-667.
38. Soker S., Takashima S., Miao H.Q., Neufeld G., Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 92:1998;735-745.
39. Thiele B.J., Berger M., Huth A., Reimann I., Schwarz K., Thiele H. Tissue-specific translational regulation of alternative rabbit 15-lipoxygenase mRNAs differing in their 3′-untranslated regions. Nucl. Acids Res. 27:1999;1828-1836.
40. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J.C., Abraham J.A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266:1991;11 947-11 954.
41. Tsoi S.C., Zheng J., Xu F., Kay H.H. Differential expression of lactate dehydrogenase isozymes (LDH) in human placenta with high expression of LDH-A(4) isozyme in the endothelial cells of pre-eclampsia villi. Placenta. 22:2001;317-322.
42. Wreschner D.H., Rechavi G. Differential mRNA stability to reticulocyte ribonucleases correlates with 3′ non-coding (U)nA sequences. Eur. J. Biochem. 172:1988;333-340.
43. Zheng J., Bird I.M., Magness R.R. A cell model for studying expression of fetoplacental artery endothelial cell angiotensin II type-1 receptors and nitric oxide synthase. Med. Biochem. 1:1998;57-64.
44. Zheng J., Bird I.M., Melsaether A.N., Magness R.R. Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor- and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase in ovine fetoplacental artery endothelial cells. Endocrinology. 140:1999;1399-1407.